Combination of cancer antigen 125 and carcinoembryonic antigen can improve ovarian cancer diagnosis

Sofie Sølvsten Sørensen; Berit Jul Mosgaard

Combination of cancer antigen 125 and carcinoembryonic antigen can improve ovarian cancer diagnosis

Sofie Sølvsten Sørensen, Berit Jul Mosgaard

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

59 Citationer (Scopus)

Abstract

The purpose of the present study was to evaluate the ability of the tumour marker carcinoembryonic antigen (CEA) in combination with cancer antigen 125 (CA-125) to differentiate between malignant ovarian and malignant non-ovarian disease.

Originalsprog	Engelsk
Tidsskrift	Danish Medical Bulletin (Online)
Vol/bind	58
Udgave nummer	11
Sider (fra-til)	A4331
ISSN	1603-9629
Status	Udgivet - 2011

Citationsformater

@article{bc8e698270a249219e9f4fc518dcc485,

title = "Combination of cancer antigen 125 and carcinoembryonic antigen can improve ovarian cancer diagnosis",

abstract = "The purpose of the present study was to evaluate the ability of the tumour marker carcinoembryonic antigen (CEA) in combination with cancer antigen 125 (CA-125) to differentiate between malignant ovarian and malignant non-ovarian disease.",

author = "S{\o}rensen, {Sofie S{\o}lvsten} and Mosgaard, {Berit Jul}",

year = "2011",

language = "English",

volume = "58",

pages = "A4331",

journal = "Danish Medical Bulletin (Online)",

issn = "1603-9629",

publisher = "Almindelige Danske Laegeforening",

number = "11",

}

TY - JOUR

T1 - Combination of cancer antigen 125 and carcinoembryonic antigen can improve ovarian cancer diagnosis

AU - Sørensen, Sofie Sølvsten

AU - Mosgaard, Berit Jul

PY - 2011

Y1 - 2011

N2 - The purpose of the present study was to evaluate the ability of the tumour marker carcinoembryonic antigen (CEA) in combination with cancer antigen 125 (CA-125) to differentiate between malignant ovarian and malignant non-ovarian disease.

AB - The purpose of the present study was to evaluate the ability of the tumour marker carcinoembryonic antigen (CEA) in combination with cancer antigen 125 (CA-125) to differentiate between malignant ovarian and malignant non-ovarian disease.

M3 - Journal article

SN - 1603-9629

VL - 58

SP - A4331

JO - Danish Medical Bulletin (Online)

JF - Danish Medical Bulletin (Online)

IS - 11

ER -